James A. Karlowsky - Concepedia

Author

James A. Karlowsky

Also Known As

Andrew Walkty, Clara Weksler, Cristiane Lamas, H. J. Adam, J A Karlowsky, J Karlowsky, J. A. Karlowsky, J. Karlowsky, J.A. Karlowsky, JAMES A. KARLOWSKY

401

Publications

20.5K

Citations

H-Index

Concepts

All Affiliations

University of Manitoba Health Sciences Centre Diagnostic Services Manitoba Public Health Agency of Canada Keysight Technologies (United States)

About

James A. Karlowsky is an author at University of Manitoba specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	107	5.8K
2	Health Sciences	35	63	3.8K
3	Public Health	4	4	382
4	Natural Sciences	2	2	196
5	Engineering	1	1	57

James A. Karlowsky

227

Publications

13.5K

Citations

H-Index

Page 1

	Year	Citations
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States James A. Karlowsky, Laurie J. Kelly, Clyde Thornsberry, Antimicrobial Agents and Chemotherapy	2002	368
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001 James A. Karlowsky, Deborah C. Draghi, Mark E. Jones, Antimicrobial Agents and Chemotherapy	2003	351
Multidrug-Resistant Urinary Tract Isolates of <i>Escherichia coli:</i> Prevalence and Patient Demographics in the United States in 2000 Daniel F. Sahm, Clyde Thornsberry, David C. Mayfield, Antimicrobial Agents and Chemotherapy Escherichia ColiAntibiotic ResistanceUnited StatesBacterial PathogensConcurrent Resistance	2001	297
Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002) Mark E. Jones, Deborah C. Draghi, Clyde Thornsberry, Annals of Clinical Microbiology and Antimicrobials	2004	272
Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006 George G. Zhanel, Mel DeCorby, Nancy M. Laing, Antimicrobial Agents and Chemotherapy	2008	270
Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy Mark E. Jones, James A. Karlowsky, Deborah C. Draghi, International Journal of Antimicrobial Agents Soft Tissue InfectionsAntimicrobial SusceptibilityHealth SciencesAntimicrobial StewardshipAntibiotics	2003	230
<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016 Meredith Hackel, Masakatsu Tsuji, Yoshinori Yamano, Antimicrobial Agents and Chemotherapy	2017	225
Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000 Clyde Thornsberry, Daniel F. Sahm, Laurie J. Kelly, Clinical Infectious Diseases	2002	222
<i>In Vitro</i> Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010 Guillermo V. Sanchez, Ronald N. Master, James A. Karlowsky, Antimicrobial Agents and Chemotherapy Surveillance NetworkEscherichia Coli IsolatesU.s. OutpatientsAntibiotic ResistanceDrug Resistance	2012	216
Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 James A. Karlowsky, Mark E. Jones, Deborah C. Draghi, Annals of Clinical Microbiology and Antimicrobials	2004	210

Page 1